-
1
Mayor Isko has enough antibodies vs severe COVID-19 after 2nd dose of CoronaVac
Publicado en Manila Bulletin (2021)Artículo -
2
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2 biopharmaceutical characterization: the NISTmAb case study
Publicado 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
3
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 3 defining the next generation of analytical and biophysical techniques
Publicado 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
4
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization
Publicado 2014Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
5
Bispecific antibodies
Publicado en Springer ebooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
6
Antibody expression and production
Publicado en Springer eBooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
7
-
8
-
9
-
10